New, successful treatment for covid using nebulizer and budesonide
AmericaCanWeTalk's Debbie Georgatos just sent me links to his paper and letter to Senator Hall
'1. Case Study Report SARS-CoV-2 and The Case for Empirical Treatment by Richard P. Bartlett, MD and Alexandria Watkins, DNP
(attached includes 51 references)
Excerpt
This case study aims to reveal the identification process, diagnosis, clinical course, and management of such a distinctive case - including the patient's prodromal phase and subsequent progression of the disease in an outpatient setting utilizing telemedicine. The goal is to call attention to the success of proactive, early empirical treatment, combining a classic corticosteroid (budesonide) administered via a nebulizer and an oral macrolide antibiotic known as clarithromycin (Biaxin)
https://americacanwetalk.org/wp-content/uploads/2020/07/ColumnByDrBartlettReCOVID-5.pdf
2. Read letter to Senator Hall from Dr. Bartlett
(attached)
Excerpt
However, there is an easily deployable pre-hospital community-based treatment for Texans. I administer a common respiratory anti-inflammatory corticosteroid, Budesonide, via a nebulizer directly to the lungs at the first signs and symptoms of COVID-19 and concurrently initiate COVID-19 testing. My rationale for choosing Budesonide over other corticosteroids is that it appears to block most of the cytokine storm inflammatory chemicals that COVID-19 triggers. In addition to my discovery, other organizations and nations are reviewing inhaled Budesonide to treat COVID-19. Inhaled Budesonide is currently under study at the NIH and is also undergoing study in France. Spain and Oxford University have both, individually, announced plans to study inhaled Budesonide as a COVID-19 therapy.
Thus far, 100% of my patients appear to be symptom-free following a course of inhaled Budesonide therapy. These successful outcomes include Texans who are at the highest risk for a very poor prognosis.– For example, an elderly woman who was my patient had two types of blood cancer and was immunocompromised and undergoing chemotherapy and radiation. She is now COVID-19 recovered with inhaled Budesonide therapy. (Note: To be COVID-19 recovered is defined as symptom-free with two consecutive negative tests.) Another one of my patients on the critical end of the spectrum included an elderly woman with a 50-year history of smoking, a history of high blood pressure and thyroid disease treatment, and a surgical history of four-vessel cardiac bypass surgery. Following a course of inhaled Budesonide therapy, she was also COVID-19 recovered. Both Texans avoided a hospitalization, a ventilator, and a possible demise.
https://americacanwetalk.org/wp-content/uploads/2020/07/BartlettHall-1.pdf
3. Watch good interview with Dr. Bartlett by AmericaCanWeTalk/ Debbie Georgatos's
https://www.youtube.com/watch?v=eDSDdwN2Xcg